RFCA
GSK icon

R&F Capital Advisors’s GSK GSK Stock Holding History

R&F Capital Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$1.18M Sell
22,379
-1,216
-5% -$61.7K 0.3% 78
2016
Q4 		$1.14M Buy
+23,595
New +$1.17M 0.4% 61

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

R&F Capital Advisors's GSK Position: Q1 2017 in Review

R&F Capital Advisors reduced its GSK (GSK) stake by 5.2% in Q1 2017, selling an estimated $61.7K and leaving 22,379 shares worth $1.18M. The position accounts for 0.3% of the portfolio, ranked #78.

R&F Capital Advisors first reported a position in GSK in Q4 2016 and has held it in 2 quarters since. 787 funds tracked by Wall St. Rank hold GSK as of Q1 2017.

  • R&F Capital Advisors held 22,379 shares of GSK worth $1.18M as of Q1 2017.
  • R&F Capital Advisors sold 1,216 GSK shares in Q1 2017, an estimated $61.7K.
  • GSK made up 0.3% of R&F Capital Advisors's portfolio in Q1 2017, its #78 holding.
  • R&F Capital Advisors first reported a position in GSK in Q4 2016 and has held it in 2 quarters since.
  • 787 funds tracked by Wall St. Rank held GSK as of Q1 2017.

Based on R&F Capital Advisors's 13F filing for Q1 2017, filed 15 May 2017.